Shares in Life Healthcare Group (LHC) surged from $2.27 to hit an intraday high of $2.45 shortly after company delivered a quality 2013-14 result. The distributor of equipment used across the spinal, orthopaedic and cardiology fields generated revenues of $87.2 million, 5.6 per cent ahead of prospectus forecasts.

Earnings before interest, tax, depreciation and amortisation of $15.3 million was in line with prospectus forecasts and represented year-on-year growth of 8.4 per cent. While earnings before interest and tax margins were slightly lower at 13.9 per cent compared with 14.6 per cent in 2012-13, analysts at Bell Potter expect an improvement in 2014-15.